PD-1 expression and cytokine secretion profiles of Mycobacterium tuberculosis-specific Cd4+ T-cell subsets; potential correlates of containment in HIV-TB co-infection

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Pollock, Katrina M ^a   Montamat Sicotte, Damien J ^a,e   Grass, Lisa ^a,f   Cooke, Graham S ^b   Kapembwa, Moses S ^c   Kon, Onn M ^d   Sampson, Robert D ^a,g   Taylor, Graham P ^b   Lalvani, Ajit ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c EALING HOSPITAL NHS TRUST   (United Kingdom)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^e RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL ANTIGEN; PDCD1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFLAMMATION; LATENT TUBERCULOSIS; LYMPHOCYTE SUBPOPULATION; MALE; MIXED INFECTION; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PROTEIN EXPRESSION; RISK FACTOR; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VIRUS LOAD; BLOOD; COMPARATIVE STUDY; COMPLICATION; CYTOLOGY; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; METABOLISM; MICROBIOLOGY; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADULT; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; COINFECTION; FEMALE; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2; LATENT TUBERCULOSIS; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROGRAMMED CELL DEATH 1 RECEPTOR; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84954484265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146905     Document Type: Article

References (50)

1. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004; 350(20):2060-7. PMID: 15141044.
2. Houben RM, Crampin AC, Ndhlovu R, Sonnenberg P, Godfrey-Faussett P, Haas WH, et al. Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis. 2011; 15(1):24-31. Epub 2011/02/01. PMID: 21276292.
3. Mattila JT, Diedrich CR, Lin PL, Phuah J, Flynn JL. Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation. J Immunol. 2011; 186(6):3527-37. Epub 2011/02/15. doi: 10.4049/jimmunol.1003773 PMID: 21317393; PubMed Central PMCID: PMCPMC3311978.
4. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2005; 191(2):150-8. PMID: 15609223.
5. Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, et al. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis. 2011; 15(5):571-81. doi: 10.5588/ijtld.10.0483 PMID: 21756508; PubMed Central PMCID: PMC4067901.
6. Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, et al. Concurrent loss of costimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015; 297(1):19-32. doi: 10.1016/j.cellimm.2015. 05.005 PMID: 26071876.
7. Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med. 2006; 203(10):2223-7. PMID: 17000870.
8. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med. 2006; 12 (10):1198-202. PMID: 16917489.
9. Petrovas C, Casazza JP, Brenchley JM, Price DA, Gostick E, Adams WC, et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med. 2006; 203(10):2281-92. PMID: 16954372.
10. Porichis F, Kwon DS, Zupkosky J, Tighe DP, McMullen A, Brockman MA, et al. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade. Blood. 2011; 118(4):965-74. Epub 2011/06/10. doi: 10.1182/blood-2010-12-328070 PMID: 21652684; PubMed Central PMCID: PMCPMC3148173.
11. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIVspecific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006; 443 (7109):350-4. Epub 2006/08/22. doi: 10.1038/nature05115 PMID: 16921384.
12. Lazar-Molnar E, Chen B, Sweeney KA, Wang EJ, Liu W, Lin J, et al. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A. 2010; 107 (30):13402-7. Epub 2010/07/14. 1007394107 [pii] doi: 10.1073/pnas.1007394107 PMID: 20624978; PubMed Central PMCID: PMC2922129.
13. Jurado JO, Alvarez IB, Pasquinelli V, Martinez GJ, Quiroga MF, Abbate E, et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol. 2008; 181(1):116-25. Epub 2008/06/21. 181/1/116 [pii]. PMID: 18566376.
14. Liu XQ, Dosanjh D, Varia H, Ewer K, Cockle P, Pasvol G, et al. Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun. 2004; 72(5):2574-81. Epub 2004/04/23. PMID: 15102765; PubMed Central PMCID: PMC387854.
15. Dosanjh DP, Bakir M, Millington KA, Soysal A, Aslan Y, Efee S, et al. Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression. PLoS One. 2011; 6(12):e28754. Epub 2012/01/05. doi: 10.1371/journal.pone.0028754 PMID: 22216109; PubMed Central PMCID: PMC3247216.
16. Millington KA, Fortune SM, Low J, Garces A, Hingley-Wilson SM, Wickremasinghe M, et al. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A. 2011; 108(14):5730-5. Epub 2011/03/24. 1015153108 [pii] doi: 10.1073/pnas.1015153108 PMID: 21427227; PubMed Central PMCID: PMC3078386.
17. Pollock KM, Tam H, Grass L, Bowes S, Cooke GS, Pareek M, et al. Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study. BMJ Open. 2012; 2(2):e000762. Epub 2012/03/03. doi: 10.1136/bmjopen-2011-000762 PMID: 22382123; PubMed Central PMCID: PMC3293130.
18. Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol G, Hackforth S, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med. 2008; 148(5):325-36. PMID: 18316751.
19. Gooding S, Chowdhury O, Hinks T, Richeldi L, Losi M, Ewer K, et al. Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice. J Infect. 2007; 54(3):e169-74. Epub 2006/12/26. S0163-4453(06)00382-3 [pii] doi: 10.1016/j.jinf.2006.11.002 PMID: 17188363.
20. Dinnes J D J, Kunst H, Gibson A, Cummins E, Waugh N, Drobniewski F, Lalvani A. A systematic review of rapid diagnostic tets for the detection of tuberculosis infection. Health Technology Assessment. 2007; 11(3):1-196. PMID: 17266837
21. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet. 2004; 364(9452):2196-203. PMID: 15610806.
22. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003; 361(9364):1168-73. Epub 2003/04/11. doi: 10.1016/S0140-6736(03)12950-9 PMID: 12686038.
23. Pollock KM, Whitworth HS, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, et al. T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis. 2013; 208(6):952-68. doi: 10.1093/infdis/jit265 PMID: 23966657; PubMed Central PMCID: PMCPMC3749005.
24. Pollock KM, Montamat-Sicotte DJ, Cooke GS, Kapembwa MS, Kon OM, Grass L, et al. Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection. Immun Inflamm Dis. 2015; 3(3):141-53. doi: 10.1002/iid3.50 PMID: 26417433; PubMed Central PMCID: PMCPMC4578516.
25. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005; 19(18):2109-16. Epub 2005/11/15. 00002030-200512020-00007 [pii]. PMID: 16284460.
26. Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005; 19(11):1113-24. Epub 2005/07/02. 00002030-200507220-00005 [pii]. PMID: 15990564.
27. Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol. 2005; 174(2):1037-45. PMID: 15634928.
28. Harari A, Petitpierre S, Vallelian F, Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood. 2004; 103(3):966-72. Epub 2003/09/06. [pii]. PMID: 12958069.
29. Boaz MJ, Waters A, Murad S, Easterbrook PJ, Vyakarnam A. Presence of HIV-1 Gag-specific IFNgamma+ IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol. 2002; 169(11):6376-85. Epub 2002/11/22. PMID: 12444145.
30. Casey R, Blumenkrantz D, Millington K, Montamat-Sicotte D, Kon OM, Wickremasinghe M, et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One. 2010; 5(12):e15619. Epub 2010/12/24. doi: 10.1371/journal.pone. 0015619 PMID: 21179481; PubMed Central PMCID: PMC3001879.
31. Day CL, Abrahams DA, Lerumo L, Janse van Rensburg E, Stone L, O'Rie T, et al. Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load. J Immunol. 2011; 187(5):2222-32. Epub 2011/07/22. jimmunol.1101122 [pii] doi: 10.4049/jimmunol.1101122 PMID: 21775682; PubMed Central PMCID: PMC3159795.
32. Lalvani A, Millington KA. T Cells and Tuberculosis: Beyond Interferon-gamma. J Infect Dis. 2008; 197 (7):941-3. Epub 2008/04/19. doi: 10.1086/529049 PMID: 18419531.
33. Pollock KM, Montamat-Sicotte D. J., Cooke G. S., Kapembwa M. S., Kon O. M., Grass L., Sampson R. D., Taylor G. P. and Lalvani A. Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection. Immunity, Inflammation and Disease. 2015. doi: 10.1002/iid3.50
34. Day CL, Mkhwanazi N, Reddy S, Mncube Z, van der Stok M, Klenerman P, et al. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J Infect Dis. 2008; 197(7):990-9. PMID: 18419535. doi: 10.1086/529048
35. Geldmacher C, Schuetz A, Ngwenyama N, Casazza JP, Sanga E, Saathoff E, et al. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J Infect Dis. 2008; 198(11):1590-8. Epub 2008/11/13. doi: 10.1086/593017 PMID: 19000013; PubMed Central PMCID: PMC2650495.
36. Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010; 207(13):2869-81. Epub 2010/12/01. jem.20100090 [pii] doi: 10.1084/jem.20100090 PMID: 21115690; PubMed Central PMCID: PMC3005236.
37. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, Nicod LP, et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med. 2011; 17(3):372-6. Epub 2011/02/22. nm.2299 [pii] doi: 10.1038/nm.2299 PMID: 21336285.
38. Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, et al. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol. 2009; 183(2):1120-32. Epub 2009/07/01. doi: 10.4049/jimmunol.0900182 PMID: 19564339; PubMed Central PMCID: PMC2923541.
39. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, et al. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008; 5(5):e100. doi: 10.1371/journal.pmed.0050100 PMID: 18462013; PubMed Central PMCID: PMCPMC2365971.
40. Cockerham LR, Jain V, Sinclair E, Glidden DV, Hartogenesis W, Hatano H, et al. Programmed death-1 expression on CD4(+) and CD8(+) T cells in treated and untreated HIV disease. AIDS. 2014; 28 (12):1749-58. PMID: 24871455; PubMed Central PMCID: PMCPMC4206412.
41. Periasamy S, Dhiman R, Barnes PF, Paidipally P, Tvinnereim A, Bandaru A, et al. Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation With Mycobacterium tuberculosis. J Infect Dis. 2011; 203(9):1256-63. Epub 2011/03/09. doi: 10.1093/infdis/jir011 PMID: 21383382; PubMed Central PMCID: PMC3069733.
42. Antonelli LR, Mahnke Y, Hodge JN, Porter BO, Barber DL, DerSimonian R, et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood. 2010; 116(19):3818-27. Epub 2010/07/28. doi: 10.1182/blood-2010-05-285080 PMID: 20660788; PubMed Central PMCID: PMC2981537.
43. Mahnke YD, Greenwald JH, DerSimonian R, Roby G, Antonelli LR, Sher A, et al. Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. Blood. 2012; 119(13):3105-12. Epub 2012/01/06. doi: 10.1182/blood-2011-09-380840 PMID: 22219223; PubMed Central PMCID: PMC3321870.
44. Jurado JO, Pasquinelli V, Alvarez IB, Martinez GJ, Laufer N, Sued O, et al. ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIVrelated illness with pulmonary tuberculosis. Journal of the International AIDS Society. 2012; 15(2):1-7. Epub 2012/06/21. doi: 10.7448/IAS.15.2.17428 PMID: 22713261.
45. Young JM, Adetifa IM, Ota MO, Sutherland JS. Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment. PLoS One. 2010; 5(6):e11237. Epub 2010/06/25. doi: 10.1371/journal.pone.0011237 PMID: 20574540; PubMed Central PMCID: PMC2888639.
46. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol. 2010; 40(8):2211-20. Epub 2010/06/12. doi: 10.1002/eji.201040455 PMID: 20540114.
47. Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, Beverley PC, et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol. 2008; 181(7):4955-64. Epub 2008/09/20. 181/7/4955 [pii]. PMID: 18802099; PubMed Central PMCID: PMC2867031.
48. Day CL, Tameris M, Mansoor N, van Rooyen M, de Kock M, Geldenhuys H, et al. Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults. Am J Respir Crit Care Med. 2013; 188(4):492-502. Epub 2013/01/12. doi: 10.1164/rccm.201208-1385OC PMID: 23306546.
49. Matthews K, Ntsekhe M, Syed F, Scriba T, Russell J, Tibazarwa K, et al. HIV-1 infection alters CD4(+) memory T cell phenotype at the site of disease in extrapulmonary tuberculosis. European Journal of Immunology. 2011. Epub 2012/01/05. doi: 10.1002/eji.201141927 PMID: 22215422.
50. Leroux-Roels I, Forgus S, De Boever F, Clement F, Demoitie MA, Mettens P, et al. Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial. Vaccine. 2012. Epub 2012/05/31. doi: 10.1016/j.vaccine.2012.05.035 PMID: 22643213.